Menu
GeneBe

BCAS3

BCAS3 microtubule associated cell migration factor, the group of WD repeat domain containing

Basic information

Region (hg38): 17:60677452-61392838

Links

ENSG00000141376NCBI:54828OMIM:607470HGNC:14347Uniprot:Q9H6U6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Hengel-Maroofian-Schols syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hengel-Maroofian-Schols syndromeARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic; Ophthalmologic34022130

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BCAS3 gene.

  • Inborn genetic diseases (38 variants)
  • not provided (5 variants)
  • BCAS3-related condition (2 variants)
  • Hengel-Maroofian-Schols syndrome (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCAS3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
41
clinvar
1
clinvar
42
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 1 1 41 2 1

Variants in BCAS3

This is a list of pathogenic ClinVar variants found in the BCAS3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-60679530-C-T Global developmental delay • Hengel-Maroofian-Schols syndrome Pathogenic/Likely pathogenic (Sep 12, 2023)993267
17-60683995-A-G Inborn genetic diseases Uncertain significance (Jan 24, 2024)3133336
17-60689725-A-G Inborn genetic diseases Uncertain significance (Mar 08, 2024)3133323
17-60689735-T-C Inborn genetic diseases Uncertain significance (Dec 14, 2021)2267365
17-60747213-C-T Global developmental delay Likely pathogenic (Jan 12, 2021)1048567
17-60747234-C-T Inborn genetic diseases Uncertain significance (Dec 19, 2023)3133333
17-60747235-A-C Inborn genetic diseases Uncertain significance (Jun 24, 2022)2297504
17-60747262-T-A Hengel-Maroofian-Schols syndrome Likely pathogenic (-)2664164
17-60808006-G-C Inborn genetic diseases Uncertain significance (Dec 22, 2023)3133334
17-60868628-AT-A Global developmental delay Likely pathogenic (Jan 12, 2021)993274
17-60868675-C-A Global developmental delay Likely pathogenic (Jan 12, 2021)1048568
17-60868682-C-T Inborn genetic diseases Uncertain significance (May 18, 2022)2401090
17-60874669-G-T Inborn genetic diseases Uncertain significance (Dec 13, 2022)2364294
17-60889701-A-G Inborn genetic diseases Uncertain significance (Jan 19, 2022)2272244
17-60889730-A-G Inborn genetic diseases Likely benign (Jul 11, 2023)2610707
17-60889745-C-T Inborn genetic diseases Uncertain significance (Aug 30, 2021)2371628
17-60889759-T-G Global developmental delay • Hengel-Maroofian-Schols syndrome Pathogenic/Likely pathogenic (Sep 12, 2023)993268
17-60902642-G-A Inborn genetic diseases Uncertain significance (Dec 02, 2022)2275297
17-60910599-G-A Inborn genetic diseases Uncertain significance (Mar 27, 2023)2530234
17-60910613-G-A Inborn genetic diseases Uncertain significance (May 27, 2022)2291740
17-60910614-A-C Inborn genetic diseases Uncertain significance (Nov 03, 2022)2322267
17-60910620-C-T Inborn genetic diseases Uncertain significance (Jan 31, 2023)2461479
17-60910629-G-A Inborn genetic diseases Uncertain significance (Oct 05, 2023)3133335
17-60910640-C-T Inborn genetic diseases Uncertain significance (Jan 04, 2022)2289689
17-60924424-T-G Inborn genetic diseases Uncertain significance (Feb 13, 2024)3133313

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BCAS3protein_codingprotein_codingENST00000390652 24715386
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001381.001247710371248080.000148
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.603755460.6870.00003076050
Missense in Polyphen153224.410.681782416
Synonymous0.2261921960.9790.00001141840
Loss of Function4.801857.20.3150.00000358574

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004490.000449
Ashkenazi Jewish0.0002000.000199
East Asian0.0001670.000167
Finnish0.0001390.000139
European (Non-Finnish)0.0001070.000106
Middle Eastern0.0001670.000167
South Asian0.00009880.0000980
Other0.0001650.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in angiogenesis. Participates in the regulation of cell polarity and directional endothelial cell migration by mediating both the activation and recruitment of CDC42 and the reorganization of the actin cytoskeleton at the cell leading edge. Promotes filipodia formation (By similarity). Functions synergistically with PELP1 as a transcriptional coactivator of estrogen receptor-responsive genes. Stimulates histone acetyltransferase activity. Binds to chromatin. {ECO:0000250|UniProtKB:Q8CCN5, ECO:0000269|PubMed:17505058}.;
Disease
DISEASE: Note=A chromosomal aberration involving BCAS3 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS4.;
Pathway
Ectoderm Differentiation (Consensus)

Intolerance Scores

loftool
0.479
rvis_EVS
-0.75
rvis_percentile_EVS
13.67

Haploinsufficiency Scores

pHI
0.637
hipred
Y
hipred_score
0.682
ghis
0.537

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.948

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Bcas3
Phenotype
cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;

Gene ontology

Biological process
angiogenesis;Golgi organization;positive regulation of endothelial cell migration;microtubule organizing center organization;negative regulation of GTPase activity;tube formation;response to starvation;positive regulation of catalytic activity;positive regulation of GTPase activity;positive regulation of transcription by RNA polymerase II;positive regulation of filopodium assembly;negative regulation of focal adhesion assembly;cellular response to estrogen stimulus;positive regulation of intracellular protein transport;activation of GTPase activity;regulation of establishment of cell polarity;positive regulation of actin cytoskeleton reorganization
Cellular component
nucleus;nucleolus;cytoplasm;cytoplasmic microtubule;cell leading edge;transcriptionally active chromatin;intermediate filament cytoskeleton;cell periphery
Molecular function
chromatin binding;protein binding;transcription factor binding;acetyltransferase activator activity;histone acetyltransferase binding;nuclear hormone receptor binding;histone binding;beta-tubulin binding